# Post-Market Clinical Study of the PanOptix Intraocular Lens (IOL) in a Chinese Population

> **NCT04755231** · NA · COMPLETED · sponsor: **Alcon Research** · enrollment: 181 (actual)

## Conditions studied

- Aphakia
- Presbyopia

## Interventions

- **DEVICE:** AcrySof IQ PanOptix Presbyopia Correcting IOL
- **PROCEDURE:** Cataract surgery

## Key facts

- **NCT ID:** NCT04755231
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-19
- **Primary completion:** 2022-08-31
- **Final completion:** 2023-03-15
- **Target enrollment:** 181 (ACTUAL)
- **Last updated:** 2023-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04755231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04755231, "Post-Market Clinical Study of the PanOptix Intraocular Lens (IOL) in a Chinese Population". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04755231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*